Postpartum Hemorrhage References

REFERENCES

Anderson JM, Etches D. Prevention and management of postpartum hemorrhage. Am Fam Physician. 2007 Mar;75(6):875-882. PMID: 17390600
International Confederation of Midwives, International Federation of Gynecology and Obstetrics, and Society of Obstetricians and Gynaecologists of Canada. Management of the third stage of labor to prevent postpartum hemorrhage. J Obstet Gynaecol Can. 2003 Nov;25(11):952-955. http://sogc.org. PMID: 14608446
Firouzbakht M, Kiapour A, Omindar S. Prevention of postpartum hemorrhage by rectal Misoprostol: a randomized clinical trial. J Nat Sci Biol Med. 2013 Jan;4(1):134-137. doi: 10.4103/0976-9668.107277. PMID: 23633849
Lalonde A; International Federation of Gynecology and Obstetrics. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012 May;117(2):108-118. doi: 10.1016/j.ijgo.2012.03.001. PMID: 22502595
Martel MJ, MacKinnon KJ, Arsenault MY, et al. Hemorrhagic shock. J Obstet Gynaecol Can. 2002 Jun;24(6):504-511. PMID: 12196857
Maughan KL, Heim SW, Galazka SS. Preventing postpartum hemorrhage: managing the third stage of labor. Am Fam Physician. 2006 Mar;73(6):1025-1028. PMID: 16570736
Leduc D, Senikas V, Lalonde AB, et al. Active management of the third stage labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009 Oct;31(10):980-993. PMID: 19941729
Schuurmans N, Mackinnon C, et al. Prevention and management of postpartum hemorrhage. J Soc Obstet Gynaecol Can. 2000;22(4):271-281.
Shane B; Program for Appropriate Technology in Health (PATH). Preventing postpartum hemorrhage: managing the third stage of labor. Outlook. 2001 Sep;19(3):1-8
Mousa HA, Alfirevic Z. Treatment of primary postpartum haemorrhage: managing the third stage of labor. Cochrane Database Syst Rev. 2007 Jan(1):CD003249. http://www.ncbi.nlm.nih.gov/pubmed/?term=17253486. PMID: 17253486
Gabbe S. Postpartum hemorrhage. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics normal and problem pregnancies. 4th. New York: Churchill Livingstone, Inc; 2002:521-536.
Cunningham F, Macdonald P, et al. Obstetrical hemorrhage. William's Obstetrics. 20th. Stamford: Appleton and Lange; 1997.
MedWormhttp://www.medworm.com/rss/index.php/OBGYN/29/http://www.medworm.com/rss/medicalfeeds/specialities/OBGYN.xml
National Institute for Health and Care Excellence. Intrapartum care. Care of healthy women and their babies during childbirth. NICE. http://www.nice.org.uk. Sep 2007.
The Royal Women’s Hospital. Labour: management of post-partum haemorrhage, including postnatal care. http://www.thewomens.org.au. Mar 2012. Accessed 10 May 2013.
Demott K, Bick D, Norman R, et al. 2006 Clinical guidelines and evidence review for postnatal care: routine postnatal care of recently delivered women and their babies. London. National Collaborating Centre for Primary Care and Royal College of General Practitioners. http://www.nice.org.uk. 2006.
Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Green-top guideline no. 52. http://www.rcog.org.uk. 2009. Accessed 10 May 2013.
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. WHO. http://apps.who.int. 2012. Accessed 26 Apr 2013.
Smith JR, Brennan BG. Postpartum hemorrhage. eMedicine. http://emedicine.medscape.com. Accessed 04 Jun 2010.
Yiadom MY, Carusi D. Pregnancy, postpartum hemorrhage. eMedicine. http://emedicine.medscape.com. Accessed 04 Jun 2010.
Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;8:CD000494. doi: 10.1002/14651858.CD000494.pub4. PMID: 22895917
Belfort MA. Overview of postpartum hemorrhage. UpToDate. https://www.uptodate.com. 29 Mar 2017. Accessed 02 May 2017.
Mavrides E, Allard S, Chandraharan E, et al on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage: Green-top guideline no. 52. BJOG. 2017 Apr;124(5):e106-e149. doi: 10.1111/1471-0528.14178. Accessed 02 May 2017. PMID: 27981719
Chandraharan E, Krishna A. Diagnosis and management of postpartum haemorrhage. BMJ. 2017 Sep 27;358:j3875. doi: 10.1136/bmj.j3875. Accessed 24 Sep 2018. PMID: 28954732
Demers C, Derzko C, David M, et al. No. 163-Gynaecological and obstetric management of women with inherited bleeding disorders. J Obstet Gynaecol Can. 2018 Feb;40(2):e91-e103. doi: 10.1016/j.jogc.2017.11.036. Accessed 24 Sep 2018. PMID: 29447730
ClinicalKey. Clinical overview: postpartum hemorrhage. ClinicalKey. https://clinicalkey.com. 25 Mar 2021.
Gonzalez-Brown V, Schneider P. Prevention of postpartum hemorrhage. Semin Fetal Neonatal Med. 2020 Oct;25(5):101129. doi: 10.1016/j.siny.2020.101129. Accessed 11 May 2021. PMID: 32782215
Henriquez DDCA, Bloemenkamp KWM, van der Bom JG. Management of postpartum hemorrhage: how to improve maternal outcomes?. J Thromb Haemost. 2018 Jun. doi: 10.1111/jth.14200. PMID: 29883040
Muñoz M, Stensballe J, Ducloy-Bouthors AS, et al. Patient blood management in obstetrics: prevention & treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus. 2019 Mar;17(2):112-136. doi: 10.2450/2019.0245-18. Accessed 11 May 2021. PMID: 30865585
D'Alton ME, Rood KM, Smid MC, et al. Intrauterine vacuum-induced hemorrhage-control device for rapid treatment of postpartum hemorrhage. Obstet Gynecol. 2020 Nov;136(5):882-891. doi: 10.1097/AOG.0000000000004138. PMID: 329099
Escobar MF, Nassar AH, Theron G, et al. FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynaecol Obstet. 2022 Mar;157(Suppl 1):3–50. doi: 10.1002/ijgo.14116. PMID: 35297039
Haslinger C, Weber K, Zimmermann R. Vacuum-induced tamponade for treatment of postpartum hemorrhage. Obstet Gynecol. 2021 Sep 1;138(3):361-365. doi: 10.1097/AOG.0000000000004510. PMID: 34352848
Robinson D, Basso M, Chan C, et al. Guideline no. 431: postpartum hemorrhage and hemorrhagic shock. J Obstet Gynaecol Can. 2022 Dec;44(12):1293-1310.e1. doi: 10.1016/j.jogc.2022.10.002. PMID: 36567097
Weeks AD, Akinola OI, Amorim M, et al. World Health Organization recommendation for using uterine balloon tamponade to treat postpartum hemorrhage. Obstet Gynecol. 2022 Mar;139(3):458-462. doi: 10.1097/AOG.0000000000004674. PMID: 35115478

Updates in the Management of Osteoporotic Fracture Risk

Dr. Chionh Siok Bee, Dr. Charles A Inderjeeth, 29 Nov 2018

Osteoporosis is a bone condition characterized by reduced bone mass and microarchitectural deterioration of bone tissue, consequently increasing bone fragility and fracture susceptibility.¹ Despite being a major cause of death and disability, osteoporosis is significantly underdiagnosed and undertreated in Asia.² At a recent symposium supported by the Osteoporosis Society (Singapore) and organized by Amgen, local expert Dr Chionh Siok Bee presented an overview of the fracture landscape in Singapore, while internationally renowned guest speaker Dr Charles A Inderjeeth discussed the importance of identifying and managing osteoporosis fracture risk, with a focus on the role of antiresorptive agent denosumab.

MONALEESA-2: Compelling survival data with ribociclib a ‘step forward’ in HR+/HER2- ABC

15 Nov 2021

Adding ribociclib (KISQALI, Novartis) to letrozole yields significant and consistent overall survival (OS) benefit compared with letrozole alone in the first-line setting for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC), according to the final OS analysis of the MONALEESA-2 trial presented at ESMO 2021.

The safe and rational use of ulipristal for fibroids

Dr. Siow Yew Ming Anthony, 20 Jun 2019

Fibroids or leiomyomas are the most common benign smooth muscle tumours of the uterus. They are often detected at screening ultrasound in asymptomatic patients. A fibroid will naturally grow until menopause and subsequently shrink when female hormone levels drop.